Nicotine inhibits the production of proinflammatory mediators in human monocytes by suppression of I‐κB phosphorylation and nuclear factor‐κB transcriptional activity through nicotinic acetylcholine receptor α7
暂无分享,去创建一个
M. Kurokawa | N. Suzuki | H. Yoshikawa | K. Nara | H. Kamochi | E. Takada | N. Suzuki | N. Ozaki | K. Atou
[1] J. F. Herrero,et al. All-trans retinoic acid induces COX-2 and prostaglandin E2 synthesis in SH-SY5Y human neuroblastoma cells: involvement of retinoic acid receptors and extracellular-regulated kinase 1/2 , 2007, Journal of Neuroinflammation.
[2] H. Berthoud,et al. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway , 2005, Nature Immunology.
[3] L. Ulloa. The vagus nerve and the nicotinic anti-inflammatory pathway , 2005, Nature Reviews Drug Discovery.
[4] K. Tracey,et al. Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation , 2005, The Journal of experimental medicine.
[5] S. Ozaki,et al. Involvement of Th1 cells and heat shock protein 60 in the pathogenesis of intestinal Behçet's disease , 2005, Clinical and experimental immunology.
[6] H. Nagafuchi,et al. Excessive expression of Txk, a member of the Tec family of tyrosine kinases, contributes to excessive Th1 cytokine production by T lymphocytes in patients with Behcet's disease , 2005, Clinical and experimental immunology.
[7] M. Huber,et al. Adenosine and cAMP are potent inhibitors of the NF‐κB pathway downstream of immunoreceptors , 2005 .
[8] M. Huber,et al. Adenosine and cAMP are potent inhibitors of the NF-kappa B pathway downstream of immunoreceptors. , 2005, European journal of immunology.
[9] M. A. Ajmone-Cat,et al. Activation of α7 nicotinic acetylcholine receptor by nicotine selectively up-regulates cyclooxygenase-2 and prostaglandin E2 in rat microglial cultures , 2005, Journal of Neuroinflammation.
[10] Hui-Yi Lin,et al. Nicotine enhancement of lipopolysaccharide/interferon-gamma-induced cytotoxicity with elevating nitric oxide production. , 2004, Toxicology letters.
[11] B. Foxwell,et al. Interleukin‐10 suppression of myeloid cell activation — a continuing puzzle , 2004, Immunology.
[12] K. Tracey,et al. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis , 2004, Nature Medicine.
[13] M. Nouri-Shirazi,et al. Nicotinic environment affects the differentiation and functional maturation of monocytes derived dendritic cells (DCs). , 2004, Immunology letters.
[14] P. Godowski,et al. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis. , 2004, Arthritis and rheumatism.
[15] S. Targan,et al. Bacterial flagellin is a dominant antigen in Crohn disease. , 2004, The Journal of clinical investigation.
[16] D. Brunzell,et al. In vivo nicotine treatment regulates mesocorticolimbic CREB and ERK signaling in C57Bl/6J mice , 2003, Journal of neurochemistry.
[17] E. Bayna,et al. Nicotine inhibits cardiac apoptosis induced by lipopolysaccharide in rats. , 2003, Journal of the American College of Cardiology.
[18] Kevin J. Tracey,et al. Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation , 2002, Nature.
[19] Wenzheng Zhang,et al. Signal transducers and activators of transcription 3 (STAT3) inhibits transcription of the inducible nitric oxide synthase gene by interacting with nuclear factor kappaB. , 2002, The Biochemical journal.
[20] D. K. Berg,et al. Voltage-Gated Channels Block Nicotinic Regulation of CREB Phosphorylation and Gene Expression in Neurons , 2001, Neuron.
[21] T. Ikeuchi,et al. Nicotine‐induced phosphorylation of extracellular signal‐regulated protein kinase and CREB in PC12h cells , 2001, Journal of neurochemistry.
[22] George Kollias,et al. Interleukin‐10 targets p38 MAPK to modulate ARE‐dependent TNF mRNA translation and limit intestinal pathology , 2001, The EMBO journal.
[23] I. Day,et al. Microarray analysis of nicotine-induced changes in gene expression in endothelial cells. , 2001, Physiological genomics.
[24] C. Brampton,et al. An investigation into the effect and mechanisms of action of nicotine in inflammatory bowel disease , 2000, Inflammation Research.
[25] K. Tracey,et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin , 2000, Nature.
[26] G. Burmester,et al. Identification of known and novel genes in activated monocytes from patients with rheumatoid arthritis. , 2000, Arthritis and rheumatism.
[27] M. Mayo,et al. Interleukin-10 Signaling Blocks Inhibitor of κB Kinase Activity and Nuclear Factor κB DNA Binding* , 1999, The Journal of Biological Chemistry.
[28] M. Mayo,et al. Interleukin-10 signaling blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA binding. , 1999, The Journal of biological chemistry.
[29] Koichi Ito,et al. Nicotine inhibits the production of inflammatory mediators in U937 cells through modulation of nuclear factor-kappaB activation. , 1998, Biochemical and biophysical research communications.
[30] K. Patil,et al. Nicotine and smokeless tobacco effects on gingival and peripheral blood mononuclear cells. , 1998, Journal of clinical periodontology.
[31] G. K. Johnson,et al. Nicotine effects on PGE2 and IL‐1β release by LPS‐treated human monocytes , 1996 .
[32] G. K. Johnson,et al. Nicotine effects on PGE2 and IL-1 beta release by LPS-treated human monocytes. , 1996, Journal of periodontal research.
[33] Peng Wang,et al. Interleukin (IL)-10 Inhibits Nuclear Factor B (NFB) Activation in Human Monocytes , 1995, The Journal of Biological Chemistry.